A commentary on “Comparison of survival benefit and safety between surgery following conversion therapy versus surgery alone in patients with surgically resectable hepatocellular carcinoma at CNLC IIb/IIIa stage: a propensity score matching study”

Department of Oncology and Hematology, People's Hospital of Leshan, Leshan, 614000, Sichuan Province, China Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. Published online ■ ■ *Corresponding Author Address: Department of Oncology and Hematology, People's Hospital of Leshan, No. 238, Baita Street, Shizhong District, Leshan, 614000, Sichuan Province, China. Tel: +86 15892925098. E-mail address: [email protected] (J. Luo). This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/